Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.
Saved in:
| Title: | Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort. |
|---|---|
| Authors: | Mangialardi V; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy., Macchitella G; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy., Vitobello R; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy., Teofilo A; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy., Cavalli N; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132, Genoa, Italy.; MS Center, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Lapucci C; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132, Genoa, Italy.; MS Center, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Vercellino M; Multiple Sclerosis Center and Neurologia I U, Department of Neuroscience and Mental Health, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy., Idini E; Multiple Sclerosis Centre, ASL Cagliari, Cagliari, Italy.; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Frau J; Multiple Sclerosis Centre, ASL Cagliari, Cagliari, Italy.; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Iaffaldano P; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy., Cavalla P; Multiple Sclerosis Center and Neurologia I U, Department of Neuroscience and Mental Health, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.; Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy., Inglese MM; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132, Genoa, Italy.; MS Center, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Cocco E; Multiple Sclerosis Centre, ASL Cagliari, Cagliari, Italy.; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Paolicelli D; Neurology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy. damiano.paolicelli@uniba.it. |
| Source: | Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 279-287. Date of Electronic Publication: 2026 May 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
